Publications by the researcher in collaboration with GUILLERMO VELASCO DÍEZ (45)

2024

  1. Cytotoxicity, Proapoptotic Activity and Drug-like Potential of Quercetin and Kaempferol in Glioblastoma Cells: Preclinical Insights

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

  2. Ingeniería Genética en H5P: promoviendo la participación del alumnado a través de la ludificación

    III Jornada «Aprendizaje Eficaz con TIC en la UCM» (Ediciones Complutense), pp. 157-168

  3. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1

    Molecular Oncology, Vol. 18, Núm. 3, pp. 620-640

2023

  1. Ludificación y mentoría en Ingeniería Genética: construcción de unjuego docente sobre la infraestructura LAMP

    II Jornada «Aprendizaje Eficaz con TIC en la UCM» (Ediciones Complutense), pp. 41-52

2022

  1. The phantom menace: cómo salvar el mundo de una pandemia mediante ingeniería genética cooperativa.

    Jornada «Aprendizaje Eficaz con TIC en la UCM» (Universidad Complutense de Madrid), pp. 301-311

2021

  1. AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity

    Nature, Vol. 592, Núm. 7856, pp. 799-803

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer

    Cancers, Vol. 13, Núm. 21

2020

  1. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

    The Journal of experimental medicine, Vol. 217, Núm. 6

  2. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells

    Theranostics, Vol. 10, Núm. 11, pp. 5120-5136

2019

  1. Inhibiting SUMO1-mediated SUMOylation induces autophagy-mediated cancer cell death and reduces tumour cell invasion via RAC1

    Journal of Cell Science, Vol. 132, Núm. 20

2018

  1. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma

    Biochemical Pharmacology, Vol. 157, pp. 275-284

  2. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide

    Biochemical Pharmacology, Vol. 157, pp. 266-274

2017

  1. Corrigendum to “The use of cannabinoids as anticancer agents” [Prog. Neuro-Psychopharmacol. Biol. Psychiatry 64 (2016) 259–266](S0278584615001190)(10.1016/j.pnpbp.2015.05.010)

    Progress in Neuro-Psychopharmacology and Biological Psychiatry

2016

  1. Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization

    Autophagy, Vol. 12, Núm. 11, pp. 2213-2229

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase

    Clinical Cancer Research, Vol. 22, Núm. 10, pp. 2508-2519

  4. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

    Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656

  5. The use of cannabinoids as anticancer agents

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 64, pp. 259-266

2015

  1. AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation

    Nature Cell Biology, Vol. 17, Núm. 1, pp. 20-30